医学临床研究
  2025年4月6日 星期日           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2024, Vol. 41 Issue (6): 900-902    DOI: 10.3969/j.issn.1671-7171.2024.06.028
  论著 本期目录 | 过刊浏览 | 高级检索 |
血清谷丙转氨酶/谷草转氨酶联合癌胚抗原预测肝细胞癌术后患者预后的价值
李海林a, 刘东b, 唐金玉a*
上海杨思医院:a.检验科;b.肝外科,上海 200126
The Predictive Value of Serum Alanine Aminotransferase/Aspartate Aminotransferase Combined with Carcinoembryonic Antigen for Postoperative Prognosis in Patients with Hepatocellular Carcinoma
LI Hailin, LIU Dong, TANG Jinyu
Department of Laboratory Medicine,Yangsi Hospital of Shanghai,Shanghai 200126
全文: PDF (1304 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨血清谷丙转氨酶/谷草转氨酶(ALT/AST)联合癌胚抗原(CEA)预测肝细胞癌术后患者预后的价值。【方法】本院经手术治疗的91例肝细胞癌患者,术后随访3年,统计存活情况,比较死亡和存活患者的临床相关资料,分析影响死亡的因素及血清ALT/AST联合CEA预测预后的价值。【结果】91例患者失访9例,其余82例中,共28例死亡,54例存活。死亡组患者低分化、Child-Pugh分级B级、远处转移构成比及血清CEA水平均高于存活组(P<0.05),死亡组患者ALT/AST低于存活组(P<0.05)。远处转移、ALT/AST、CEA是影响患者死亡的独立危险因素(OR=4.158、4.039、4.067,P<0.05);血清ALT/AST联合CEA预测肝细胞癌患者术后死亡的特异度和曲线下面积(AUC)分别为96.30%和0.946,其预测价值高于ALT/AST、CEA单独检测。【结论】临床检测血清ALT/AST和CEA可作为预测肝细胞癌患者术后死亡的敏感指标,二者联合检测的预测价值更高。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
李海林
刘东
唐金玉
关键词 肝细胞/外科学丙氨酸转氨酶/血液天冬氨酸氨基转移酶类/血液癌胚抗原    
Abstract:【Objective】 To investigate the predictive value of serum alanine aminotransferase/aspartate aminotransferase(ALT/AST) combined with carcinoembryonic antigen(CEA) for postoperative prognosis in patients with hepatocellular carcinoma(HCC).【Methods】 Ninety-one HCC patients treated surgically in our hospital were followed up for three years postoperatively. The survival status was recorded, and clinical data of deceased and surviving patients were compared. Factors influencing mortality and the predictive value of serum ALT/AST combined with CEA for prognosis were analyzed.【Results】 Of the 91 patients, 9 were lost to follow-up. Among the remaining 82 patients, 28 died and 54 survived. The proportion of poorly differentiated tumors, Child-Pugh grade B and distant metastasis in the deceased group were higher than those in the surviving group(P<0.05). The serum CEA levels in the deceased group were higher than that in the surviving group(P<0.05). The ALT/AST ratio in the deceased group was lower than that in the surviving group(P<0.05). Distant metastasis, ALT/AST, and CEA were independent risk factors for mortality(OR=4.158, 4.039, and 4.067, respectively,P<0.05). The specificity and area under the curve(AUC) for predicting postoperative mortality in HCC patients using serum ALT/AST combined with CEA were 96.30% and 0.946, respectively, indicating higher predictive value than using ALT/AST or CEA alone.【Conclusion】 Clinical detection of serum ALT/AST and CEA can serve as sensitive indicators for predicting postoperative mortality in HCC patients, with combined detection offering higher predictive value.
Key wordsCarcinoma, Hepatocellular/SU    Alanine Transaminase/BL    Aspartate Aminotransferases/BL    Carcinoembryonic Antigen
收稿日期: 2023-08-26     
中图分类号:  R735.7  
通讯作者: *E-mail:T_jinyu@126.com   
引用本文:   
李海林, 刘东, 唐金玉. 血清谷丙转氨酶/谷草转氨酶联合癌胚抗原预测肝细胞癌术后患者预后的价值[J]. 医学临床研究, 2024, 41(6): 900-902.
LI Hailin, LIU Dong, TANG Jinyu. The Predictive Value of Serum Alanine Aminotransferase/Aspartate Aminotransferase Combined with Carcinoembryonic Antigen for Postoperative Prognosis in Patients with Hepatocellular Carcinoma. JOURNAL OF CLINICAL RESEARCH, 2024, 41(6): 900-902.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.06.028     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I6/900
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn